Blood-Based Biomarker Test for Colorectal Cancer Results

A blood-based biomarker test for colorectal cancer is a screening or detection tool that looks for signs of cancer-related changes in the blood. These tests are gaining attention because they are less invasive than colonoscopy and may help detect colorectal cancer earlier. If you have already taken one, you may be wondering what the results mean, whether they are accurate, and what the next steps are.

This article explains how these tests work, how to understand positive and negative results, and what a blood-based biomarker test can and cannot tell you about colorectal cancer. For readers who want a broader overview of symptoms and related concerns, it can also help to review bleeding hemorrhoid causes and when to worry since rectal bleeding may have more than one possible explanation.

What Is a Blood-Based Biomarker Test for Colorectal Cancer?

A blood-based biomarker test checks a blood sample for biological signals, or biomarkers, that may be linked to colorectal cancer. These markers can include:

• Circulating tumor DNA (ctDNA)
• DNA methylation patterns
• Protein markers
• Other molecular changes associated with cancer

The goal is to detect evidence that cancer may be present, or in some cases, to help monitor disease after treatment.

Unlike a colonoscopy, which looks directly inside the colon and rectum, a blood test looks for indirect signs of disease in the bloodstream. That makes it simpler and more convenient, but it also means it may not be as definitive as a direct visual exam.

Why These Tests Are Used

Blood-based biomarker tests are used for several reasons:

• To screen for possible colorectal cancer
• To support early detection
• To monitor for recurrence in some patients
• To provide an option for people who are reluctant to undergo stool-based or colonoscopy screening

In many cases, these tests are most useful as part of a broader screening strategy, not as a replacement for all other tests. According to the National Cancer Institute, screening tests are most effective when they are used in the right risk group and followed by appropriate confirmation when needed: Colorectal cancer screening facts from the National Cancer Institute.

How to Interpret Blood-Based Biomarker Test Results

Understanding your result depends on the type of test used, but most results fall into one of two categories:

• Positive result: The test found biomarkers associated with colorectal cancer
• Negative result: The test did not detect these biomarkers

Some tests may also return an indeterminate, inconclusive, or borderline result, meaning the sample could not be clearly classified.

Positive Result

A positive blood-based biomarker test does not always mean you have colorectal cancer. It means the test detected signals that may be consistent with cancer and that more testing is usually needed.

Possible next steps after a positive result often include:

• Colonoscopy
• Imaging tests
• Repeat testing, depending on the situation
• Discussion with a healthcare provider about your risk factors and symptoms

A positive result should be taken seriously, but it is not a final diagnosis.

Negative Result

A negative result means the test did not find concerning biomarkers in your blood. This can be reassuring, but it does not guarantee that colorectal cancer is absent.

Why a negative result is not absolute:

• Some cancers may not shed enough biomarkers into the blood
• Early-stage cancers may be harder to detect
• Test sensitivity can vary
• Other non-cancer factors can affect results

If you have symptoms such as rectal bleeding, unexplained weight loss, abdominal pain, or a change in bowel habits, a negative test should not be used to rule out a medical evaluation.

Inconclusive or Borderline Result

An inconclusive result may happen if:

• The blood sample was insufficient
• Biomarker levels were near the detection threshold
• The test quality was affected by technical factors

In this case, your doctor may recommend repeating the test or using another screening method.

How Accurate Are Blood-Based Biomarker Tests?

Accuracy varies by test. The two most important measures are:

• Sensitivity: How well the test detects people who actually have cancer
• Specificity: How well the test correctly identifies people who do not have cancer

A highly sensitive test reduces false negatives, while a highly specific test reduces false positives. No test is perfect.

In general, blood-based biomarker tests may perform well in detecting more advanced cancers, but they may be less reliable for very early-stage disease or precancerous polyps. That is important because early detection is one of the main goals of colorectal cancer screening.

People often compare this approach with stool testing or colonoscopy because each method answers a slightly different question. Blood testing may be easier to complete, but a direct exam still provides more detail when a clinician needs to confirm the source of symptoms.

What Happens After a Positive Result?

If your blood-based biomarker test result is positive, your healthcare provider will usually recommend follow-up testing. The most common next step is a colonoscopy because it allows doctors to directly examine the colon and remove or biopsy suspicious growths.

A positive result may also lead to:

• A discussion of personal and family history
• Review of symptoms
• Additional tests if colonoscopy is not immediately possible
• Referral to a gastroenterologist or cancer specialist

Do not assume a positive result means cancer is confirmed. Follow-up testing is essential to determine the cause.

For some people, the best next step is not just confirming the blood test result but also reviewing any other causes of bleeding or bowel symptoms. If rectal bleeding is part of the story, a clinician may also consider other gastrointestinal conditions before deciding on the full workup.

What Happens After a Negative Result?

If your result is negative, your doctor may tell you to continue routine screening based on your age, family history, and risk level.

However, a negative result does not mean you should ignore:

• Blood in the stool
• Ongoing abdominal discomfort
• Iron deficiency anemia
• Unexplained fatigue
• Changes in stool shape or frequency

If you are at higher risk for colorectal cancer, you may still need colonoscopy or other recommended screening tests even after a negative blood-based biomarker test.

It is also worth remembering that a reassuring result only applies to the time the sample was taken. New symptoms or ongoing concerns still deserve medical follow-up.

Who Should Consider This Type of Test?

A blood-based biomarker test may be considered by people who:

• Are due for colorectal cancer screening
• Prefer a blood draw over stool-based tests
• May have barriers to completing colonoscopy
• Need additional evaluation in certain clinical situations

That said, the best screening option depends on your risk profile. People with a personal history of colorectal polyps, inflammatory bowel disease, strong family history, or genetic risk may need more intensive screening.

If you are unsure whether blood testing is appropriate, your clinician can help compare it with stool-based testing, colonoscopy, and any other screening plan that fits your risk level.

Can a Blood Test Replace Colonoscopy?

In most cases, no. A blood-based biomarker test can be a useful screening tool, but colonoscopy remains the most comprehensive method for colorectal cancer detection and prevention.

Why colonoscopy is still important:

• It can find and remove precancerous polyps
• It directly visualizes the colon lining
• It provides tissue samples for diagnosis

Blood tests may be more convenient, but colonoscopy is still the most definitive follow-up when a result is abnormal or when someone is at elevated risk.

If you want to learn more about another blood-related condition that can also cause concern around bleeding, see bladder fistula symptoms, causes, and treatment options for a separate but important example of why accurate diagnosis matters.

Common Questions About Blood-Based Biomarker Test Results

Does a positive result mean I definitely have cancer?

No. A positive result means the test found markers linked to colorectal cancer, but more testing is needed to confirm what is causing them.

Can colorectal cancer be missed with a negative result?

Yes. No test detects every case. Early-stage cancers or some polyps may not trigger a positive blood test.

How soon should I follow up after an abnormal result?

Follow-up should happen as soon as your healthcare provider recommends. Prompt evaluation is important, especially if you have symptoms.

Are these tests used for diagnosis?

They may help identify who needs further evaluation, but they are generally not used alone to diagnose colorectal cancer.

Are blood-based biomarker tests approved or recommended for everyone?

Recommendations depend on the specific test, your age, and your risk level. Your clinician can help determine whether this is an appropriate screening option.

Factors That Can Affect Results

Several factors can influence blood-based biomarker test results:

• Cancer stage
• Tumor biology
• Test technology
• Sample handling
• Other medical conditions

Because of this, results should always be interpreted in context. Your age, family history, symptoms, and prior screening history all matter.

Test performance also depends on how much tumor material is present in the bloodstream at the time of sampling. That is one reason the same test can behave differently in different patients.

When to Talk to a Doctor

You should speak with a healthcare professional if:

• Your blood-based biomarker test is positive
• You have symptoms of colorectal cancer
• You have a family history of colorectal cancer
• You are unsure whether this test is right for you
• You received an inconclusive result

Even if your result is negative, medical advice is important if you are having concerning symptoms or are overdue for screening.

Seek timely care if symptoms persist or become worse, especially when bowel changes happen along with weight loss, anemia, or visible blood. Those patterns may need evaluation beyond a single screening test.

The Bottom Line

A blood-based biomarker test for colorectal cancer looks for signs of cancer in the bloodstream and can be a convenient screening tool. A positive result usually means more testing is needed, while a negative result is reassuring but not definitive. Because accuracy is not perfect, these tests work best as part of an overall screening plan rather than as the only method of detection.

If you have results from a blood-based biomarker test, the most important step is to review them with a healthcare provider who can explain what they mean for your specific situation and help determine whether further testing is needed.

For more information about the role of screening and why follow-up matters, the U.S. Preventive Services Task Force offers a helpful evidence summary on colorectal cancer screening: USPSTF colorectal cancer screening recommendation.